Jaap J.M. Teunissen

Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Dik J. Kwekkeboom, Jaap J.M. Teunissen, Willem H. Bakker et al. · Journal of Clinical Oncology · 2005 · 659 citations · Full text

Medicine, Oncology, Pharmacology +15

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen et al. · Clinical Cancer Research · 2017 · 604 citations

Medicine, Oncology, Pharmacology +17

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

Dik J. Kwekkeboom, Willem H. Bakker, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 422 citations · Full text

Medicine, Nuclear Medicine, Oncology +10

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

Flavio Forrer, Eric P. Krenning, P.P.M. Kooij et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 207 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Quality of Life in Patients With Gastroenteropancreatic Tumors Treated With [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate

Jaap J.M. Teunissen, Dik J. Kwekkeboom, Eric P. Krenning · Journal of Clinical Oncology · 2004 · 196 citations

Medicine, Nuclear Medicine, Oncology +16